5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

M.K. Sutherland, C.P. Yu, M. Anderson, W.P. Zeng, N. van Rooijen, E.L. Sievers, I.S. Grewal, C.L. Law

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)440-448
JournalMABS
Volume2
Issue number4
DOIs
Publication statusPublished - 2010

Cite this

Sutherland, M. K., Yu, C. P., Anderson, M., Zeng, W. P., van Rooijen, N., Sievers, E. L., ... Law, C. L. (2010). 5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. MABS, 2(4), 440-448. https://doi.org/10.4161/mabs.12203
Sutherland, M.K. ; Yu, C.P. ; Anderson, M. ; Zeng, W.P. ; van Rooijen, N. ; Sievers, E.L. ; Grewal, I.S. ; Law, C.L. / 5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. In: MABS. 2010 ; Vol. 2, No. 4. pp. 440-448.
@article{c9f9a1d9a59c4fa1984317804764d8eb,
title = "5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia",
author = "M.K. Sutherland and C.P. Yu and M. Anderson and W.P. Zeng and {van Rooijen}, N. and E.L. Sievers and I.S. Grewal and C.L. Law",
year = "2010",
doi = "10.4161/mabs.12203",
language = "Undefined/Unknown",
volume = "2",
pages = "440--448",
journal = "MABS",
issn = "1942-0862",
publisher = "Landes Bioscience",
number = "4",

}

Sutherland, MK, Yu, CP, Anderson, M, Zeng, WP, van Rooijen, N, Sievers, EL, Grewal, IS & Law, CL 2010, '5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia' MABS, vol. 2, no. 4, pp. 440-448. https://doi.org/10.4161/mabs.12203

5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. / Sutherland, M.K.; Yu, C.P.; Anderson, M.; Zeng, W.P.; van Rooijen, N.; Sievers, E.L.; Grewal, I.S.; Law, C.L.

In: MABS, Vol. 2, No. 4, 2010, p. 440-448.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - 5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

AU - Sutherland, M.K.

AU - Yu, C.P.

AU - Anderson, M.

AU - Zeng, W.P.

AU - van Rooijen, N.

AU - Sievers, E.L.

AU - Grewal, I.S.

AU - Law, C.L.

PY - 2010

Y1 - 2010

U2 - 10.4161/mabs.12203

DO - 10.4161/mabs.12203

M3 - Article

VL - 2

SP - 440

EP - 448

JO - MABS

JF - MABS

SN - 1942-0862

IS - 4

ER -